Paul Matthew Herrinton

Title: Paul Matthew Herrinton: Innovator in Antiviral Agents

Introduction

Paul Matthew Herrinton is a notable inventor based in Portage, MI (US). He has made significant contributions to the field of antiviral agents, particularly in the treatment of herpesvirus infections. His innovative work has led to the development of a unique compound that holds promise for pharmaceutical applications.

Latest Patents

Herrinton holds a patent for a compound known as 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents. This invention provides a compound of formula I, wherein G, R, R, and R have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof. The patent also outlines processes and intermediates useful for preparing such compounds or salts, as well as methods of treating herpesvirus infections using these compounds or salts. He has 1 patent to his name.

Career Highlights

Throughout his career, Herrinton has worked with prominent organizations, including Pfizer Corporation. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of antiviral research.

Collaborations

Some of his notable coworkers include Sajiv Krishnan Nair and Mark E Schnute. Their collaboration has likely contributed to the advancements in the projects they have worked on together.

Conclusion

Paul Matthew Herrinton's contributions to antiviral agents demonstrate his commitment to advancing medical science. His innovative patent and collaborations highlight his role as a significant figure in the field of pharmaceuticals.